Short Interest in Cosmos Health Inc. (NASDAQ:COSM) Decreases By 19.5%

Cosmos Health Inc. (NASDAQ:COSM) saw a significant decline in short interest in the month of March. As of March 15th, there was short interest totalling 646,900 shares, a decline of 19.5% from the February 28th total of 804,000 shares. Based on an average daily volume of 414,400 shares, the short-interest ratio is presently 1.6 days. Currently, 4.0% of the company’s shares are sold short.

Cosmos Health Stock Performance

Shares of Cosmos Health stock opened at $0.45 on Monday. Cosmos Health has a 52 week low of $0.35 and a 52 week high of $1.58. The firm has a market capitalization of $10.49 million, a P/E ratio of -0.18 and a beta of 5.60. The company has a quick ratio of 1.24, a current ratio of 1.44 and a debt-to-equity ratio of 0.08. The firm’s 50 day moving average is $0.61 and its two-hundred day moving average is $0.71.

Insiders Place Their Bets

In related news, CEO Grigorios Siokas bought 132,572 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The stock was purchased at an average cost of $0.49 per share, for a total transaction of $64,960.28. Following the completion of the acquisition, the chief executive officer now owns 4,029,588 shares in the company, valued at approximately $1,974,498.12. This trade represents a 3.40 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders have bought 832,506 shares of company stock valued at $502,164 over the last ninety days. Company insiders own 15.61% of the company’s stock.

Institutional Trading of Cosmos Health

A hedge fund recently raised its stake in Cosmos Health stock. Geode Capital Management LLC raised its stake in shares of Cosmos Health Inc. (NASDAQ:COSM) by 29.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 193,432 shares of the company’s stock after acquiring an additional 43,704 shares during the period. Geode Capital Management LLC owned approximately 0.83% of Cosmos Health worth $129,000 as of its most recent SEC filing. Institutional investors and hedge funds own 12.61% of the company’s stock.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.